AT-1501 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01 (month) in 3mo
ESTIMATED |
READOUT
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney
Phase 1/2 · Prevention of Rejection in Kidney Transplant |
ELDN Eledon Pharmaceuticals, Inc. | AT-1501 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|